Abstract
Introduction
Atherosclerosis is a widespread pathology involving the entire body. The ankle-brachial pressure index (ABPI) is an easily accessible and inexpensive test that can be performed at the bedside to make the diagnosis of PAD in symptomatic patients and to determine the vascular risk in asymptomatic patients [1] . Having a low ABPI is an independent risk factor for the cardiovascular disease and its fatal or non-fatal complications [2] .
Hyperhomocysteinemia causes endothelial dysfunction and atherosclerosis. It is a risk factor for many macrovascular diseases [3, 4] . High levels of homocysteine are more frequent in patients with coronary artery disease (CAD), cerebrovascular disease (CVD), and peripheral artery disease (PAD) [3] . Hyperhomocysteinemia develops as a result of the deficiencies of the enzymes.
Furthermore, cofactor deficiencies (vitamin B12, vitamin B6, and folic acid), drugs, and conditions causing endothelial dysfunction (diabetes, hypertension, dyslipidemia, renal failure, inflammatory intestinal diseases, systemic lupus, hypothyroidism, smoking, drugs) can also cause hyperhomocysteinemia [5] .
Modestly high concentrations of C-reactive protein (CRP), the classical acute phase protein, are associated with the long-term risk of coronary heart disease in general populations. The major acute phase response of CRP following myocardial infarction (MI) is associated with death and cardiac complications [6] .
The purpose of our study was to measure ABPI and homocysteine levels and to investigate frequency of CAD and/or PAD combination in patients with MI.
Materials and Methods
39 patients hospitalized in the coronary intensive care unit with diagnosis acute or subacute MI (26 female, 13 male) and 36 control cases (27 female, 9 male) were included in the study.
Inclusion criteria of patients were being without any known chronic diseases (PAD, diabetes mellitus, cardiac insufficiency, chronic renal insufficiency, CVD, hypertension) and younger than 75 years of age. Subjects without CAD history, with normal ECG, and without any known systemic disorder were included in the control group. Blood samples were collected from the patients and the controls at 8 AM after 12-hour fasting. Serum triglyceride (TG) and total Coronary angiography was performed in all patients after acute or subacute disease had become stable.
Body mass index (BMI) was calculated according to the formula body weight divided by the square of the height (kg/m2). American Heart Association recommendations were taken into consideration for ABPI calculation. Blood pressure were measured the patients after they rested for 5 minutes in the supine position from the brachial arteries in both arms and from the one pedal artery on each of the lower extremities. The ABPI was found by dividing the highest systolic pressure of brachial artery by the highest systolic pressure of lower extremity. Reference value of the ABPI was taken as > 0.9 [7] . Written informed consent was taken by the participants. This study was approved by local ethics committee, and complied with the declaration of Helsinki.
Results
Thirty-nine patients diagnosed with acute or subacute MI, and 36 control cases were included in the study. There were no differences between the patient and control groups regarding mean age and gender distribution (59±7.9 and 56.8±9.7 years; respectively; p=0.632). Table 2 ). Angiographically, single coronary vessel ± branch involvement was present in 48% of patients, two coronary vessels ± branch involvement was present in 35.8%, and 3 coronary vessels ± branch involvement was present in 15.5% of patients. (Figure 1 ). However, there were no statistically significant differences between the groups in terms of vitamin B12 and FA (326.7±204.6 pg/ml; 312.1±183.5 pg/ml; p=0.7 and 9.1±4.0 ng/ml; 9.5±2.4 ng/ml; p=0.394, Table 2 ). No significant correlation was found between the number of affected coronary vessels and the level of homocysteine (p>0.05). Figure 1 ). However the frequency of patients with lower ABPI (≤0.9) was significantly higher compared to the frequency of control patients with lower ABPI (25.6% and 3.0%, respectively; p=0.02, Table 3 ). There was no statistically significant relationship between ABPI with the number of affected coronary arteries (p>0.05). implemented as an easy and noninvasive method for early determination of atherosclerotic lesions in the lower extremity arteries. Many studies have shown that PAD incidence increases in cases with ABPI ≤0.9. Low ABPI values in patients with CAD were related the existence of PAD and the number of affected coronary arteries [8, 9] . In our study, the mean ABPI was 1.06±0.22 in the patient group and 1.12±0.18 in the control group. No statistically significant differences between the patient and control groups were observed in terms of ABPI (Table 2, Figure 1 ). No significant correlation was found between the ABPI values and the number of coronary arteries involved in patients with ABPI ≤0.9. Relatively small number of cases may cause these different results.
However the frequency of low ABPI (≤0.9) was significantly higher compared to the control patients (Table 3) .
Since atherosclerosis plays a role in the pathogenesis of each, the possibility of co-occurrence of vascular diseases such as CAD, PAD, and CVD is high. Different ratios have been reported in the literature for the combination of CAD and CVD. In patients candidate coronary artery bypass operation, the accompaniment of carotid stenosis ≥50% has been reported with diverse rates between 3.8% and 22% [10] [11] [12] . Merino et al found a strong relationship between PAD and the incidence of major cardiovascular events [13] . Uzun et al found the ABPI was significantly lower in patients with CAD compared to those without CAD. Again, a significant relationship was found between the severity of coronary disease and ABPI [14] . We found atherosclerotic changes in peripheral arteries in 25.6% of patients. This combination was lower compared to the accompaniment of CAD by carotid arterial lesions (59.0%). 20.5% of the patients had atherosclerotic changes both in the peripheral arteries and carotid-vertebral arteries ( Figure 2 ).
CRP is a marker of inflammation that has been shown in multiple prospective epidemiological studies to predict incident MI, stroke, peripheral arterial disease, and sudden cardiac death. CRP levels have also been shown to predict risk of both recurrent ischemia and death among those with stable and unstable angina, those undergoing percutaneous angioplasty, and those presenting to emergency rooms with acute coronary syndromes [15] . Similar to CRP, fibrinogen levels also increase following acute MI. It is related with the prognosis of the diseases and is an independent risk factor for the development of MI [16] . In our study, CRP and fibrinogen levels were significantly higher in the patients as compared to control cases as expected (Table 2, Figure 1 ).
There was no relationship between the number of coronary arteries involved, CRP, and fibrinogen levels.
Homocysteine is an independent risk factor for atherosclerosis [17, 18] . High homocysteine level is seen in patients with intimal-medial wall thickening in the carotid artery. Robinson et al found a positive correlation between increased serum homocysteine levels and increasing CAD risk [19] .
Ubbink et al found hyperhomocysteinemia in 41.9% of the patients with CAD, and observed that homocysteine levels were significantly higher in those with two or three occluded coronary arteries [20] . Tokgözoğlu et al showed that homocysteine levels exceeding 15 µmol/L were present in half of those with CAD and hyperhomocysteinemia increased coronary risk by 2.1-fold [21] . In our study, high homocysteine levels were likewise found in 74.4% of the cases with CAD while they were 18.2% in the control groups. Homocysteine was significantly higher compared to the control (Table 2, Figure 1 ). However, no significant correlation was found between the number of coronary vessels involved and the level of homocysteine (p>0.05).
The accompaniment of CAD by other major atherosclerotic vascular diseases such as PAD and CVD, and atherosclerotic risk factors such as the homocysteine level and ABPI was examined in this study. Homocysteine, CRP and fibrinogen levels were significantly higher in our patient group, as expected. Literature data that low ABPI values (≤0.9), which is used for the early diagnosis of peripheral arterial lesions, and particularly lower extremity arterial lesions, could also predict CAD was confirmed in our study.
On the other hand, we found that severe CAD was more significantly combined with CVD cases than PAD. Based on this finding, screening of CVD should be done in patients with MI history. In 
